• NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies

  • Feb 29 2024
  • Duración: 20 m
  • Podcast

NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies  Por  arte de portada

NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies

  • Resumen

  • In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podcast. In this episode, Dr. Robertson presents an overview of NMOSD treatment, including goals, triggers, and considerations for switching therapies. DA-UNBR-US-02296-2 05/2024 Sponsored by Horizon Therapeutics
    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.